Hybrid ablation is a new minimally invasive treatment option for patients with persistent or difficult-to-treat atrial fibrillation (AFib). AFib is a quivering or irregular heartbeat (arrhythmia) caused by an abnormality of the heart’s electrical system. At The Valley Hospital Heart & Vascular Institute, a customized hybrid ablation treatment has been developed to treat this type of Afib and is performed by a collaborative team of cardiac specialists that includes a cardiac surgeon and an electrophysiologist, a cardiologist who specializes in the diagnosis and treatment of heart rhythm disorders (arrhythmias).
Hybrid ablation at Valley is an innovative treatment that is a combination of the catheter and surgical approaches to cardiac ablation. It is one of the first to truly integrate both a video-scope and catheter approach into a single procedure. Hybrid ablation is performed through three small incisions in the abdomen and a few small punctures in both groins. There are no large chest incisions or ports placed within the chest. No instruments are passed through the ribs, and the breastbone is left completely intact. The patient’s heart is never stopped during hybrid ablation, so there is no need for a heart-lung bypass machine.
Patients generally stay one to two nights in the hospital; they are monitored closely during their recovery before being discharged to home.
The customized hybrid ablation procedure that is performed at the Heart & Vascular Institute by our cardiac is done in Valley’s electrophysiology lab, not in an operating room, at the hospital’s main campus at 223 North Van Dien Avenue in Ridgewood, New Jersey.